Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-22-044297
Filing Date
2022-04-08
Accepted
2022-04-08 16:53:26
Documents
4
Effectiveness Date
2022-04-08

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2212133d1_s8.htm S-8 41245
2 EXHIBIT 5.1 tm2212133d1_ex5-1.htm EX-5.1 16295
3 EXHIBIT 23.1 tm2212133d1_ex23-1.htm EX-23.1 2345
4 EXHIBIT 107 tm2212133d1_ex107.htm EX-FILING FEES 16487
  Complete submission text file 0001104659-22-044297.txt   77632
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-264211 | Film No.: 22817674
SIC: 2834 Pharmaceutical Preparations